Hague – A New Consideration For US Design Applications | Law360

Knobbe Martens partner Carol Pitzel Cruz was quoted in a recent Law360 article on the Federal Circuit’s decision in Wyeth v. AstraZeneca, a patent infringement dispute centered on Section 112...

In interviews with World Trademark Review, MLex, and Women’s Wear Daily, Knobbe Martens partner Ben Katzenellenbogen shared his insights on a recent California district court decision in a design patent...

Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance, “about” may...